MeSH tree: D09.400.420.925
In a randomized pilot study recently published in the Journal for ImmunoTherapy of Cancer, an international research team led by Andrea Facciabene, Ph.D., and Steven Joel Feigenberg, MD, both of the Department of Radiation ...
Jul 29, 2025
0
14
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during antibiotic therapy.
A fecal transplant performs as well as antibiotics in treating people with a bacterial infection that can cause life-threatening diarrhea, a new study says.
Jun 20, 2025
0
23
Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been in use for more than 80 years, but only now have consensus guidelines been proposed on prescribing ...
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the Centers for Disease Control ...
Mar 18, 2025
0
19
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Feb 10, 2025
0
51
Research from Chalmers University of Technology, Sweden, shows that resistant bacteria can regain susceptibility to antibiotics when the treatment is combined with a material equipped with antibacterial peptides. The study, ...
Nov 18, 2024
0
11
Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. "The idea was to tweak the original antibiotic and create ...
Aug 8, 2024
0
140
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from the University of Houston ...
Apr 25, 2024
0
65
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in combating the resilient ...
Dec 19, 2023
0
33
